Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1951296
Max Phase: Preclinical
Molecular Formula: C23H28Cl2N4O2S
Molecular Weight: 495.48
Molecule Type: Small molecule
Associated Items:
ID: ALA1951296
Max Phase: Preclinical
Molecular Formula: C23H28Cl2N4O2S
Molecular Weight: 495.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)Cc1cccc(-c2cc(Cl)c(S(=O)(=O)Nc3c(C)nn(C)c3C)c(Cl)c2)c1
Standard InChI: InChI=1S/C23H28Cl2N4O2S/c1-6-29(7-2)14-17-9-8-10-18(11-17)19-12-20(24)23(21(25)13-19)32(30,31)27-22-15(3)26-28(5)16(22)4/h8-13,27H,6-7,14H2,1-5H3
Standard InChI Key: AGAPYTXFHCVDOQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 495.48 | Molecular Weight (Monoisotopic): 494.1310 | AlogP: 5.65 | #Rotatable Bonds: 8 |
Polar Surface Area: 67.23 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 6.58 | CX Basic pKa: 9.57 | CX LogP: 3.40 | CX LogD: 3.34 |
Aromatic Rings: 3 | Heavy Atoms: 32 | QED Weighted: 0.44 | Np Likeness Score: -1.86 |
1. Brand S, Cleghorn LA, McElroy SP, Robinson DA, Smith VC, Hallyburton I, Harrison JR, Norcross NR, Spinks D, Bayliss T, Norval S, Stojanovski L, Torrie LS, Frearson JA, Brenk R, Fairlamb AH, Ferguson MA, Read KD, Wyatt PG, Gilbert IH.. (2012) Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors., 55 (1): [PMID:22148754] [10.1021/jm201091t] |
2. (2015) N-myristoyl transferase inhibitors, |
Source(2):